Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Hala S. Abdel Kawy"'
Autor:
Fatmah A. Bakhdar, MSc, Hala S. Abdel kawy, PhD, Rania M. Magadmi, PhD, Eman A. El-Kordy, PhD, Abdulhakeem S. Alamri, PhD
Publikováno v:
Journal of Taibah University Medical Sciences, Vol 18, Iss 1, Pp 9-18 (2023)
الملخص: أهداف البحث: يعتبر مثبط المناعة (التاكروليموس) أهم مسبب للإصابة بنوع السكري الجديد ما بعد زراعة الكلى. تهدف الدراسة لتقييم فعالية
Externí odkaz:
https://doaj.org/article/5181aa960145458c84a4c4eb9abab3cf
Autor:
Reem Alyoubi, Abdullah Althomali, Rania Magadmi, Hala S. Abdel kawy, Hadiah Bassam Al Mahdi, Fatemah O. Kamel, Duaa M. Bakhshwin, Maha Jamal, Mohammed Alsieni
Publikováno v:
Medicina, Vol 58, Iss 11, p 1593 (2022)
Background and Objectives: Epilepsy is a chronic brain disease, with inherent and noninherent factors. Although over 20 anti-seizure medications (ASMs) are commercially available, nearly one-third of patients develop drug-resistant epilepsy. We evalu
Externí odkaz:
https://doaj.org/article/7b5fe966169f4021a0235f12f368e720
Autor:
Fatmah A. Bakhdar, Hala S. Abdel kawy, Rania M. Magadmi, Eman A. El-Kordy, Abdulhakeem S. Alamri
Publikováno v:
Journal of Taibah University Medical Sciences. 18(1)
The immunosuppressant tacrolimus is a major cause of new-onset diabetes after transplantation. The aim of this study was to evaluate whether a low dose of the histone-deacetylase inhibitor (vorinostat) might ameliorate tacrolimus-induced new-onset di
Autor:
Hala S. Abdel Kawy, Walaa Baher, Mahdy Salama Abou Zeid, Esraa Moustafa ELnahas, Nevien Hendawy
Publikováno v:
Life Sciences. 163:23-37
Aim Depression associating patients with chronic liver diseases is a major treatment goal. This study aimed to evaluate the potential hepatoprotective and antidepressant effects of celecoxib in a model of experimental autoimmune hepatitis (EAH) and d
Autor:
Hala S. Abdel Kawy
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 13:455-463
Airway inflammation in chronic obstructive pulmonary disease (COPD) is refractory to corticosteroids and hence COPD treatment is hindered and insufficient. This study assessed the effects of oral treatment with Montelukast (10 and 30 mg/kg) or dexame
Autor:
Yousria Saad Wahba, Reeham Mohamed Hussein, Amany H Hasanin, Ghada Galal Hamam, Hala S. Abdel Kawy, Osama Mahmod Elsirafy
Publikováno v:
Life Sciences. 136:100-107
Aim A low dose of theophylline enhances histone deacetylase activity leading to inhibition of proinflammatory transcription, and inhibits lung fibroblast proliferation. The present work investigated the effect of low dose theophylline on biochemical
Autor:
Hala S. Abdel Kawy
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 93:443-450
Recent findings from septic acute renal injury studies have implicated the mitochondrion as an important factor in kidney injury, and that increased sympathetic nerve activity may contribute to the induction of organ failure. This study investigated
Publikováno v:
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Various antiepileptic drugs (AEDs) especially enzyme-inducing AEDs might be associated with increased vascular risk, through impairment of the endogenous antioxidative ability which may trigger oxygen-dependent tissue injury. Lamotrigine (LTG) a non-
Autor:
Hala S. Abdel Kawy
Publikováno v:
Egyptian Journal of Basic and Clinical Pharmacology, Vol 2, Iss 2, Pp 23-35 (2012)
Background: Although corticosteroids are currently drugs of choice for anti-inflammatory therapy, the inflammatory process in chronic obstructive pulmonary disease (COPD) is essentially steroid- resistant. Aim: The aim of the present study was to ass
Autor:
Hala S. Abdel Kawy
Publikováno v:
European journal of pharmacology. 752
Cilostazol is a phosphodiesterase III inhibitor increases adenosine 3′, 5′-cyclic monophosphate (cyclic AMP) level which inhibits hepatic stellate cell activation. Its pharmacological effects include vasodilation, inhibition of vascular smooth mu